Creative Biolabs, a leader in live biotherapeutic product (LBP) development, is advancing gut microbiota research through a suite of cutting-edge technologies. The human gut hosts an estimated 500 to 1000 bacterial species that are critical to physiological processes, making this research vital for understanding health and disease.
The company integrates classical microbiological techniques with molecular approaches to unravel the complex interactions between humans and their gut microbiota. Key technologies include Denaturing Gradient Gel Electrophoresis (DGGE), which provides insights into gut microbial community features and instability. Fluorescence In Situ Hybridization (FISH) enables high-resolution imaging to reveal microbial structure and roles. Real-Time PCR quantifies gene expression in gut microbes, offering reliable data on microbial activities. The 16S rRNA Sequencing technique, combined with bioinformatics, determines microbial composition and interactions with host health. Culturomics, a novel culture method, allows growth of previously unculturable microbes, potentially leading to new probiotic and biotherapeutic discoveries.
Creative Biolabs provides comprehensive research support, including sample preparation from diverse sources such as human feces, intestinal contents, and various animal samples. This diversity enables comparative studies across species. The integrated LBP development platform facilitates creation of a wide range of LBPs, addressing research gaps and providing full reports and data support to explain the gut microbiome's structure and operations.
The ultimate goal is to develop precision therapies targeting the gut for personalized medicine. Understanding gut microbiota relationships with human health could yield more effective treatments for digestive disorders, immune-related diseases, and conditions like mental health and metabolic disorders. As the gut microbiome's influence on overall health gains recognition, Creative Biolabs' advancements are paving the way for a new era of personalized medicine, where treatments are tailored based on individual microbiota profiles.
These developments have far-reaching implications for medicine, potentially revolutionizing treatment approaches. The ongoing work by Creative Biolabs is crucial for translating scientific discoveries into practical applications that improve human health, reshaping our understanding of human biology and disease treatment.
